20 April 2017
Illumina increases CVC fund to $189m
The genomics technology producer has boosted the size of the corporate venture capital unit it announced in April last year from $100m to $189m with a $250m ceiling.
Author: Robert Lavine, News Editor
US-based genomics technology provider Illumina has increased the size of its corporate venturing unit from $100m to approximately $189m and could close it at $250m, according to a securities filing on Tuesday.